A detailed history of Lindbrook Capital, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Lindbrook Capital, LLC holds 76 shares of TWST stock, worth $3,525. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76
Previous 87 12.64%
Holding current value
$3,525
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$27.95 - $53.0 $307 - $583
-11 Reduced 12.64%
76 $3,000
Q1 2024

Apr 25, 2024

BUY
$32.28 - $41.5 $1,549 - $1,992
48 Added 123.08%
87 $2,000
Q4 2023

Jan 31, 2024

SELL
$15.08 - $38.61 $150 - $386
-10 Reduced 20.41%
39 $1,000
Q3 2023

Oct 25, 2023

SELL
$18.62 - $26.57 $428 - $611
-23 Reduced 31.94%
49 $0
Q2 2023

Jul 28, 2023

SELL
$11.49 - $20.46 $218 - $388
-19 Reduced 20.88%
72 $1,000
Q1 2023

Apr 26, 2023

BUY
$14.6 - $30.9 $1,226 - $2,595
84 Added 1200.0%
91 $1,000
Q4 2022

Jan 24, 2023

SELL
$21.92 - $39.37 $591 - $1,062
-27 Reduced 79.41%
7 $0
Q3 2022

Nov 10, 2022

BUY
$33.44 - $56.56 $902 - $1,527
27 Added 385.71%
34 $1,000
Q2 2022

Aug 01, 2022

SELL
$26.2 - $54.0 $786 - $1,620
-30 Reduced 81.08%
7 $0
Q1 2022

Apr 21, 2022

SELL
$38.58 - $83.27 $2,700 - $5,828
-70 Reduced 65.42%
37 $2,000
Q4 2021

Jan 18, 2022

BUY
$75.47 - $135.88 $4,679 - $8,424
62 Added 137.78%
107 $8,000
Q3 2021

Nov 05, 2021

BUY
$95.64 - $131.48 $765 - $1,051
8 Added 21.62%
45 $5,000
Q2 2021

Jul 27, 2021

SELL
$88.13 - $142.06 $7,755 - $12,501
-88 Reduced 70.4%
37 $5,000
Q1 2021

Apr 28, 2021

BUY
$105.48 - $207.97 $9,282 - $18,301
88 Added 237.84%
125 $15,000
Q2 2020

Jul 27, 2020

BUY
$26.4 - $45.3 $976 - $1,676
37 New
37 $2,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.61B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.